Influenza A Virus PB1-F2 Gene in Recent Taiwanese Isolates by Chen, Guang-Wu et al.
Influenza A virus contains eight RNA segments and
encodes 10 viral proteins. However, an 11th protein, called
PB1-F2, was found in A/Puerto Rico/8/34 (H1N1). This
novel protein is translated from an alternative open reading
frame (ORF) in the PB1 gene. We analyzed the PB1 gene
of 42 recent influenza A isolates in Taiwan, including 24
H1N1 and 18 H3N2 strains. One H1N1 isolate and 17
H3N2 isolates contained the entire PB1-F2 ORF of 90
residues, three amino acids (aa) longer than the PB1-F2 of
A/Puerto Rico/8/34 at the C terminal. The one remaining
H3N2 isolate encoded a truncated PB1-F2 with 79
residues. The other 23 H1N1 isolates contained a truncat-
ed PB1-F2 of 57 aa. Phylogenetic analysis of both the HA
and the PB1 genes showed that they shared similar clus-
tering of these Taiwanese isolates, suggesting that no obvi-
ous reassortment occurred between the two genomic
segments.
I
nfluenza Avirus is a prevalent pathogen with substantial
pandemic potential (1). The influenza pandemic in 1918
was the most catastrophic in history, claiming more than
20 million lives (2). Influenza epidemics continue to occur
every 2 to 3 years, causing substantial illness and death.
Influenza A virus has eight segments of negative-stranded
RNA genome and encodes 10 viral proteins (3). However,
an 11th influenza A viral protein was recently found. This
new protein product was discovered serendipitously dur-
ing a systematic search of potential antigenic peptides rec-
ognized by CD8+ T lymphocytes encoded by influenza
virus A/Puerto Rico/8/34 (H1N1) (4). Unlike other
influenza A viral proteins, this novel protein has several
unusual features. It is absent from some influenza virus
isolates, expresses different levels among individual
infected cells, degrades rapidly, and localizes to mitochon-
dria. This protein is called PB1-F2 because it is translated
from an alternative open reading frame (ORF) in the PB1
gene. The PB1 gene has an inefficient start codon, accord-
ing to Kozak’s analysis (5), which explains why PB1-F2
can be translated when an alternative start codon is used at
nucleotide positions 119 to 121 based on the PB1 gene of
A/Puerto Rico/8/34 (4). 
Since PB1-F2–induced apoptosis in a cell-specific
manner and might be important in pathogenesis, do the
recently circulated influenza isolates possess the alterna-
tive ORF? This study analyzed 42 influenza A isolates in
Taiwan from 1995 to 2001. The sequence of the hemagglu-
tinin gene (HA) was also analyzed for further genetic char-
acterization of these isolates (6–8). 
Materials and Methods
Clinical Isolates
The clinical specimens examined were throat swab
specimens collected from the Clinical Virology
Laboratory, Chang Gung Memorial Hospital (Contract
Laboratory of the Center for Disease Control and
Prevention, Taiwan). The specimens were added to
Madin-Darby canin kidney (MDCK) cells. Typing of the
influenza A virus then was conducted by using immuno-
fluorescence assay (IFA) by type-specific monoclonal
antibody (Dako, Cambridgeshire, UK). Moreover, subtyp-
ing was conducted by reverse transcription–polymerase
chain reaction (RT-PCR) with subtype-specific primers
(Table) (9,10). Virus isolates were stored at –80°C until
use.
RNA Extraction and RT-PCR
The clinical isolates were passed in MDCK cells, and
the supernatant was used for viral RNAextraction with the
Viral RNA Extraction Miniprep System kit (Viogene,
Sunnyvale, CA). Viral RNA was amplified into double-
stranded DNA by RT-PCR by using the Ready-To-GoRT-
PCR Beads (Amersham Biosciences, Piscataway, NJ). The
Table lists the primers used for RT-PCR, and the RT-PCR
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Nucleotide Sequence Analysis
The RT-PCR product was purified by using the
QIAquick Gel Extraction Kit (Qiagen, Valencia, CA). The
nucleotide sequence of the purified fragments was deter-
mined by using an automated DNA sequencer. A 561- to
564-nt HA sequence was obtained for H1N1 isolates from
genomic position 120 to 683 of A/Puerto Rico/8/34
(H1N1), and an 844-nt sequence was obtained for H3N2
isolates from genomic position 187 to 1031 of A/Hong
Kong/1/68 (H3N2). A 300-nt PB1 sequence was obtained
from genomic position 104 to 403, covering the entire
PB1-F2 gene from position 119 to position 379 of
A/Puerto Rico/8/34 (H1N1). Sequence analysis, including
pairwise sequence alignment and protein translation, was
conducted with the Lasergene software, version 3.18
(DNASTAR, Madison, WI) (11). Multiple sequence align-
ment was conducted with Clustal W, version 1.81 (12),
with a gap opening penalty of 15 and a gap extension
penalty of 6.66. The phylogenetic analysis was performed
with PHYLIP (13,14), version 3.573c, with a Kimura 2-
parameter distance matrix (program dnadist) and the
neighbor joining method (program neighbor). Support for
tree topology was determined by bootstrap analysis with
1,000 pseudo-replicate datasets generated by the seqboot
program in PHYLIP. Aconsensus tree was obtained by the
consense program, and the topology was viewed with
TreeView, version 1.6.6. Secondary structures of the
sequences were predicted by using the NNPREDICT pro-
gram (http://www.cmpharm.ucsf.edu/~nomi/nnpredict.
html) (15). The reference sequences were obtained from
GenBank. All human influenza A viruses with H1N1 or
H3N2 subtypes whose PB1 genes could be translated into
a putative PB1-F2 ORF were included for comparison with
the Taiwanese strains used in this study. All human
influenza A viruses with other subtypes or nonhuman
influenza A viruses capable of being translated into PB1-
F2 were also studied. 
Nucleotide Sequence Accession Number
The nucleotide sequence data reported in this study
were deposited to the GenBank nucleotide sequence data-
base with accession numbers AY303701 to AY303752,
AF139930 to AF139940, and AF362778 to AF362820.
Results
Influenza A isolates in the Clinical Virology Laboratory
A total of 8,229 clinical specimens were received for
diagnosis of the respiratory tract virus at the Clinical
Virology Laboratory, Chang Gung Memorial Hospital,
from 1995 to 2001. Five hundred and forty-seven influen-
za Aviruses were isolated from these specimens, including
170 H1N1 and 377 H3N2 isolates. Notably, no H3N2 iso-
lates were found in 1995, and only one H1N1 isolate each
was found in 1997 and 1998 (Figure 1). 
PB1 Sequence Analysis
The start codon for the PB1 gene is located at positions
25 to 27, while the stop codon is at positions 2296 to 2298,
yielding a PB1 protein with 757 residues (16,17). The com-
plete ORF for PB1-F2 in A/Puerto Rico/8/34 (H1N1) is
from position 119 to 379, which encodes an 87-residue pro-
tein (4). To determine the existence of PB1-F2 in these
Taiwanese influenza A isolates, 42 of them were randomly
selected between 1995 and 2001, including 24 H1N1
strains and 18 H3N2 strains. Ten H1N1 and 17 H3N2 refer-
ence strains were also included for the PB1 sequence analy-
sis. The selection was based on an extensive search for all
human H1N1 and H3N2 influenza viruses in GenBank,
whose PB1 nucleotide sequences were shown to alterna-
tively translate into a PB1-F2 gene. Figures 2 and 3 show
the translated PB1-F2 amino acids for H1N1 and H3N2
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Table. Primers used for reverse transcription–polymerase chain 
reaction 
Primer/nt position  Sequence  Size (bp) 
H1F-78
a  GATGCAGACACAATATGTATAGG  611 
H1R-689
a  CICTACAGAGACATAAGCATTT   
H3F-114
b  TCAGATTGAAGTGACTAATGCT  976 
H3R-1120
b  AATTTTGATGCCTGAAACCGT   
PB1F-32
c  TCAATCCGACCTTACTTTTC  409 
PB1R-441
c  AGCAGGCTGGTTTCTATTTA   
aGenomic position based on A/Puerto Rico/8/34(H1N1) nc002017. 
bGenomic position based on A/Hong Kong/1/68(H3N2) af348176. 
cGenomic position based on A/Puerto Rico/8/34(H1N1) isdn13420. 
Figure 1. Number of isolated influenza A viruses in Clinical
Virology Laboratory, Chang Gung Memorial Hospital, a contract
laboratory of the Center for Disease Control and Prevention—
Taiwan.strains. The amino acid sequence of PB1-F2 for A/Puerto
Rico/8/34 (H1N1) was included in both figures as a tem-
plate. All 24 H1N1 influenza A viruses contained an alter-
native start codon (AUG) at positions 119 to 121 in the PB1
gene, which translated into Met (M) and marked the begin-
ning of PB1-F2 ORF. Most of these H1N1 strains encoun-
tered a stop codon (UAG) at positions 290 to 292, resulting
in the production of a 57-residue peptide and covering only
a truncated PB1-F2. One isolate A/Taiwan/3355/97
(H1N1), however, covered the entire ORF (87-residue)
because a non-stop codon UGG was found at equivalent
positions at which other Taiwanese H1N1 encountered a
stop codon. The translation continued and eventually
stopped at positions 389 to 391, which encoded a putative
protein of 90 residues, three residues longer than the PB1-
F2 protein in A/Puerto Rico/8/34. For the nine reference
strains in addition to A/Puerto Rico/8/34, three strains
(A/WSN/33, A/Fort Monmouth/1/47 and A/Wisconsin/
10/98) encoded a PB1-F2 of 90 residues, five strains
(A/Beijing/11/56, A/Fuji/15899/83, A/Charlottesville/
31/95, A/Hong Kong/470/97, and A/Hong Kong/427/98)
encoded a truncated ORF of 57 residues, and one strain
(A/Wisconsin/3523/88) encountered an exceptionally early
stop codon and ended in only 11 residues. Most of the
H3N2 isolates analyzed in this study, on the other hand,
covered the full-length of PB1-F2 ORF of 90 residues as
found in A/Taiwan/3355/97 (H1N1). Only two exceptions
were observed, including one Taiwanese strain
A/Taiwan/1748/97 with a truncated PB1-F2 ORF of 79
residues, and one reference strain A/Shiga/25/97 with 87
residues as in A/Puerto Rico/8/34 (H1N1).
The nucleotide sequence identities for PB1 gene were
96.3%–100% among the 24 Taiwanese H1N1 strains, and
97.3%–100% among the 18 H3N2 strains, based on a 300-
nt segment that covers the entire putative PB1-F2 of inter-
est. Figure 4 presents the PB1 phylogenetic tree for all 42
Taiwanese isolates and 27 previously selected reference
strains. All Taiwanese strains were grouped into their
respective subtype. The Taiwanese H1N1 strains were
divided into two clusters. One contained eleven
1995–1996 isolates, which were similar to
A/Charlottesville/31/95 and A/Hong Kong/427/98
(97.0%–98.6%), and the other contained 13 1997–2001
isolates, which were similar to A/Hong Kong/470/97
(99.0%–99.6%). The Taiwanese H3N2 strains were also
divided into two clusters, including four 1996–1997 iso-
lates similar to A/Shiga/25/97 (98.6%– 99.6%) and four-
teen 1997–2001 isolates similar to A/Hong Kong/497/97
and A/Hong Kong/498/97 (98.3%–100.0%). 
The putative PB1-F2 protein of A/Taiwan/3355/97
(H1N1) was 81.1% identical to A/Puerto Rico/8/34
(H1N1). In addition to the three extra amino acids (Trp88-
Thr89-Asn90) at the C-terminal end, A/Taiwan/3355/97
(H1N1) had 14 aa that differed from the 87-residue peptide
of A/Puerto Rico/8/34. Notably, two Arg residues, Arg75
and Arg79, which have a propensity to form an amphipath-
ic helix and may be required for membrane translocation
(4,15), had been changed to Leu75 and Gla79 in
A/Taiwan/3355/97 (H1N1). However, A/Taiwan/3351/97
(H3N2) (Figure 3), a strain that also contains a 90-residue
PB1-F2 and was isolated at approximately the same time
as A/Taiwan/3355/97 (H1N1), was only 50.0 % identical
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Figure 2. Alignment of putative PB1-F2 amino acid sequences of
24 Taiwanese H1N1 strains and 10 H1N1 reference strains. Most
strains, including 23 Taiwanese strains and 5 reference strains,
contained a truncated open reading frame (ORF) 57 residues long.
One reference strain, A/Wisconsin/3523/88, had the ORF truncat-
ed at 11 residues. PB1-F2 of A/Puerto Rico/8/34 with 87 residues
is placed on top of the alignment. One Taiwanese strain and three
reference strains each contained a complete PB1-F2 of 90
residues. The program AlignX in VectorNTI Suite produced the
alignment.
Figure 3. Alignment of putative PB1-F2 amino acid sequences of
18 Taiwanese H3N2 strains and 17 H3N2 reference strains. PB1-
F2 of A/Puerto Rico/8/34 (H1N1) with 87 residues is laid over the
alignment for reference. Most strains contained a PB1-F2 ORF 90
residues long. One Taiwanese strain, A/Taiwan/1748/97, encoded
a truncated open reading frame (ORF) with 79 residues, and one
reference strain, A/Shiga/25/97, encoded a 87-residue product as
in A/Puerto Rico/8/34 (H1N1). The program AlignX in VectorNTI
Suite produced the alignment.to A/Puerto Rico/8/34 and differed in 42 aa other than the
three trailing residues. The difference between A/Taiwan/
3355/97 (H1N1) and A/Taiwan/3351/97 (H3N2), both
with a 90-residue PB1-F2, was 37 residues; these two
strains share only 58.8% identity. 
HA Nucleotide Sequence Analysis
The HA sequences were also analyzed to elucidate the
genetic characteristics of these Taiwanese influenza A iso-
lates. Figure 5 shows the phylogenetic tree of HA for 35
H1N1 strains, including 24 Taiwanese isolates, 6 reference
strains used in earlier PB1-F2 analysis, whose HA
sequences were available in GenBank, and 5 recent H1N1
vaccine strains. The sequence identity among these 24 iso-
lates was 91.8%–100%, based on a 561- to 564-nt HAseg-
ment. Eleven 1998–2001 isolates were clustered with the
2000-2001 vaccine strain A/New Caledonia/20/99
(18–20), exhibiting a nucleotide sequence identity from
97.5% to 99.2%. Another eleven 1995-1996 isolates were
clustered with A/Bayern/7/95 (21–24), the vaccine strain
used in 1997–1998, and A/Charlottesville/31/95, exhibit-
ing a nucleotide sequence identity from 97.8% to 100%.
The other two Taiwanese isolates, A/Taiwan/3355/97 and
A/Taiwan/1184/99, were separated from the 1998–2001
Taiwanese isolates with good bootstrap values.
A/Taiwan/1184/99 was similar to A/New Caledonia/20/99,
exhibiting an identity of 99.2%. A/Taiwan/3355/97,
although further apart, was also similar to A/New
Caledonia/20/99 too with a 97.5% identity.
A/Taiwan/3355/97 was also adjacent to the preceding vac-
cine strain A/Beijing/262/95, as determined from phyloge-
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Figure 4. Phylogenetic tree of influenza Aviruses for their PB1 gene
nucleotide sequences. Apart from the 42 Taiwanese isolates
obtained in this study, 27 reference strains were included; these
were selected on the basis of an extensive search of all human
H1N1 and H3N2 influenza viruses from GenBank, whose PB1
sequences were shown to be able to be translated into the putative
PB1-F2 gene. The tree was rooted with B/Lee/40. All strains were
separated into two groups according to their subtypes. Sequence
analysis was conducted using the software Lasergene, Clustal W
and PHYLIP with 1,000 replicates. All sequences are 300-nt long
from genomic position 104 to 403 based on the PB1 gene of
A/Puerto Rico/8/34, which covers at least the entire PB1-F2.
Figure 5. Phylogenetic tree of H1N1 influenza A viruses for HA
nucleotide sequences. Five recent vaccine strains were included
along with the 24 Taiwanese strains and six reference strains con-
sidered previously in Figure 4. The tree was rooted with A/Puerto
Rico/8/34. Sequence analysis was conducted using the software
Lasergene, Clustal W, and PHYLIP with 1,000 replicates.
Sequences contained 561 to 564 nt bases from positions 120 to
683, based on A/Puerto Rico/8/34.ny and shared a 96.4% identity. Nevertheless, all 13
Taiwanese H1N1 isolates from 1997 to 2001 exhibited a
characteristic deletion mutation Lys (K) at aa 134 of the
HA gene, as has been previously reported (25). The dis-
tinct genetic feature of possessing the entire PB1-F2 ORF
in A/Taiwan/3355/97 might have separated this strain from
other 23 Taiwanese H1N1 isolates in the phylogenetic tree.
Figure 6 shows the phylogenetic tree of 37 H3N2 strains,
including 17 Taiwanese isolates, 13 reference strains used
in preceding PB1 analysis, whose HA sequences were
available, 6 recent H3N2 vaccine strains, and 1 English
strain as an outgroup. The nucleotide sequence identity in
terms of HAgene among the 17 analyzed Taiwanese H3N2
isolates from 1996 to 2001 was 96.2%–100%, based on an
844-nt HA segment, which is higher than that among the
24 Taiwanese H1N1 isolates (91.8%–100%) under investi-
gation. The two 1999 isolates were clustered with
A/Moscow/10/99 (99.6%–99.7%), which was the vaccine
strain used in 2001 to 2002 (26). The three 2000 isolates
were clustered with the 2000–2001 vaccine strain
A/Panama/2007/99 (98.8%–99.4%) (18). The eight
1997–1998 isolates formed their own cluster, despite a rel-
atively low bootstrap support, and were similar to the
1998–2000 vaccine strain A/Sydney/5/97 (98.8%–99.4%)
(24,27,28). Four other Taiwanese 1996–1997 isolates were
not grouped into any of these Taiwanese H3N2 clusters.
They were similar to A/Shiga/25/97 and the two 1996
Fukushima strains (97.5%–99.5%). 
Discussion
One isolate among the 24 Taiwanese H1N1 strains from
1996 to 2001 possessed the full-length PB1-F2 ORF. Most
of the H1N1 isolates contained a shorter 57-residue puta-
tive PB1-F2, encountering a premature stop codon at posi-
tions 290 to 292. All of the Taiwanese H3N2 isolates,
however, contained the full-length ORF from 1995 to
2001, except for A/Taiwan/1748/97, which encoded a trun-
cated PB1-F2 of 79 residues. The putative full-length PB1-
F2 of these Taiwanese strains contained 90 aa, which was
three residues longer than A/Puerto Rico/8/34 (H1N1). 
PB1-F2 of A/Puerto Rico/8/34 (H1N1) has been shown
to localize to the mitochondria and induce cell death.
According to the NNPREDICT algorithm, PB1-F2 of
A/Puerto Rico/8/34 (H1N1) tends to form an amphipathic
helix, extending from Leu69 to Phe83 (4,15). The predict-
ed helix includes five basic residues. This feature enables
PB1-F2 to translocate through the membrane, target the
mitochondria, and trigger host cell apoptosis (29). The
putative 90-residue-long PB1-F2 protein of
A/Taiwan/3355 (H1N1) and A/Taiwan/3351 (H3N2) also
possessed a predicted helix from Leu72 to Phe83.
However, A/Taiwan/3355/97 (H1N1) contained three basic
residues, and A/Taiwan/3351/97 (H3N2) contained four.
The truncated PB1-F2 (57-residue ORF of most Taiwanese
H1N1 strains or the 79-residue ORF of A/Taiwan/1748/97
[H3N2]) did not have the predicted helix. The change in
the number of basic residues in those Taiwanese strains did
not alter the result from NNPREDICT, that is, all full-
length PF1-F2 amino acid sequences (87- or 90-residue
ones) were predicted to contain a helix around the same
location. Whether the reduction in the number of basic
residues in the predicted helix, or the significant difference
between the PF1-F2 amino acids of the Taiwanese strains
and of A/Puerto Rico/8/34 (H1N1), supports functions that
differ from those of A/Puerto Rico/8/34 (H1N1), remains
to be investigated. 
The truncated PB1-F2 (with <87 or 90 aa residues) did
not contain the mitochondrial translocation signal at the
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Figure 6. Phylogenetic tree of influenza A H3N2 viruses for HA
nucleotide sequences. Six recent vaccine strains were included
along with the 17 Taiwanese strains and 13 reference strains
shown in Figure 4. The tree was rooted with A/England/939/69.
Sequence analysis was conducted by using the software
Lasergene, Clustal W, and PHYLIP with 1,000 replicates. All
sequences are 844-nt long from positions 187 to 1031, based on
A/Hong Kong/1/68.C-terminal end and may lose the PF1-F2 functions
described above. The earliest observation for such trunca-
tion of human H1N1 or H3N2 influenza A viruses was
associated with A/Beijing/11/56 (H1N1), which has been
seen in most Taiwanese H1N1 strains and four other ref-
erence strains (Figure 3), as well as in A/Taiwan/1748/98
(H3N2) (Figure 4).
All of the H1N1 Taiwanese isolates from 1997 to 2001
exhibited a stable genetic characteristic—a deletion muta-
tion at aa 134 in the HA gene. The only H1N1 isolate in
1997, A/Taiwan/3355/97, was found to encode the entire
90-residue PB1-F2 ORF, which is 3 aa longer than the
PB1-F2 of A/Puerto Rico/8/34 (H1N1). Although
A/Taiwan/3355/97 (H1N1) was found to be phylogeneti-
cally related to those isolates that encode partial PB1-F2
from 1998 to 2001 in both HA and PB1 genes, this genet-
ic marker that putatively encodes a full-length PB1-F2 was
not retained in subsequent isolates. This finding suggests
that the existence of a putative full-length PB1-F2 ORF in
the PB1 gene might have been a disadvantage to the
growth of H1N1 virus in the infected host population.
However, almost all of the H3N2 isolates analyzed in this
study encoded a full-length ORF of PB1-F2, including the
Taiwanese strains and the reference strains from GenBank.
The only exception was A/Taiwan/1748/97, which encod-
ed a truncated PF1-F2 with 79 residues. 
The 336 influenza A PB1 sequences of all species from
GenBank, including all the Taiwanese and reference
strains analyzed in this work, were collected to provide an
overall picture of how a putative PB1-F2 can be alterna-
tively translated from its PB1 gene. All 336 PB1 sequences
examined contained the entire RNA segment equivalent to
the position of PB1-F2 ORF as in A/Puerto Rico/8/34
(H1N1). Only two avian strains without a start codon were
observed (A/Quail/Hong Kong/AF157/92 [H9N2] and
A/duck/NC/91347/01 [H1N2]), leaving no PB1-F2 encod-
ed. Ninety-nine human influenza Aviruses were observed,
among which 64 encoded a 90-residue PB1-F2, two
encoded an 87-residue ORF (A/Puerto Rico/8/34 [H1N1]
and A/Shiga/25/97 [H3N2] stated early section), and 33
encoded a truncated ORF (1 strain with 79 residues, 30
with 57, and 2 with 11). Of the remaining 235 nonhuman
influenza A viruses, 191 encoded a 90-residue PB1-F2, 7
encoded an 87-residue ORF, and 37 encoded a truncated
ORF. (Twenty-three strains had 79 residues, 2 had 63; 5
had 57; 1 had 34, and 6 had 11.) Of all the 334 translated
PB1-F2, 264 (79.0%) contained a complete ORF of 87 or
90 residues.  
The complete PB1 sequences of 38 influenza Aviruses,
including 26 human and 12 nonhuman strains, were gath-
ered from GenBank to evaluate the genetic variation of the
PB1 gene and the putative PB1-F2 gene. Each sequence is
2,271 to 2,274-bp long, covering the entire coding region
of PB1 and containing a putative PB1-F2 ORF of at least
87 residues. The pairwise identities of these 38 PB1 cod-
ing sequences were from 81.2% to 99.9% for nucleotides,
and 94.3%–99.7% for the translated amino acids. For the
alternatively translated PB1-F2 ORF that is 261- to 270-bp
long, or from nucleotide position 95 to 364 with respect to
the full coding region of PB1, the pairwise identities were
79.2%–99.6% for nucleotides, and 52.2%–98.8% for the
translated amino acids. In terms of the partial sequences in
the forms of their regularly translated PB1 segments (from
position 94 to 363, or a 70-residue peptide) equivalent to a
genomic range in which the PB1-F2 is translated, the pair-
wise identities for these 38 strains were 92.2%–100.0%.
The variation among the sequences was limited to approx-
imately 20% in nucleotides and <8% in amino acids for the
complete PB1 coding region, as well as for a partial PB1
segment (position 94 to 363) corresponding to the PB1-F2
location. The alternatively translated PB1-F2 to the equiv-
alent piece of RNA (position 95 to 364), however, exhibit-
ed a large variation up to 50%. The two translations
differed by only 1 nt. Although certain single nucleotide
mutations, which might have occurred at the third position
of a codon in the original PB1 translation, did not seem to
substantially alter the resulting amino acid sequences, a
frame shift of alternatively translating the RNAinto a puta-
tive PB1-F2 apparently introduced a substantial change in
the genetic heterogeneity up to 47.8%. A single nucleotide
change can also easily introduce a stop codon under this
new translation, which might account for the observed
truncated PB1-F2 genes of various lengths. PB1-F2 pro-
tein is not essential to influenza viral replication, so this
novel gene may be subject to less selection pressure than
PB1 or HA during viral evolution. 
Phylogenic inference drawn from PB1 sequences
showed two distinct clusters within the H1N1 and H3N2
groups of the analyzed Taiwanese strains (Figure 4).
Twenty-four Taiwanese H1N1 strains were grouped into
cluster I (which contained eleven 1995–1996 strains) and
cluster II (which contained thirteen 1997–2001 strains).
This same clustering pattern was seen in the HA phyloge-
netic tree for H1N1 strains in Figure 5, in which the
eleven 1995–1996 strains joined cluster III, and the thir-
teen 1997–2001 strains were in cluster I+II. A similar
clustering pattern of 18 Taiwanese H3N2 strains was also
observed between Figures 4 and 6. Phylogenetic analysis
of both PB1 and HA genes showed no evidence of reas-
sortment for the two viral segments among these
Taiwanese isolates.
Apoptosis is an important pathogenic mechanism in
influenza Avirus infection. Differential induction of apop-
tosis was caused in the infected cells by different influen-
za virus strains (30). PB1-F2 is a mitochondrial protein
that induces apoptosis. PB1-F2 was absent from certain
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between the existence of PB1-F2 and the apoptosis level of
influenza A virus–infected cells would be of interest.
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